These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25222866)

  • 1. Clinical utility of a novel molecular assay in various combination strategies with existing methods for diagnosis of HIV-related tuberculosis in Uganda.
    Ssengooba W; Nakiyingi L; Armstrong DT; Cobelens FG; Alland D; Manabe YC; Dorman SE; Ellner JJ; Joloba ML
    PLoS One; 2014; 9(9):e107595. PubMed ID: 25222866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of Xpert MTB/RIF Ultra and culture assays to detect Mycobacterium Tuberculosis using OMNIgene-sputum processed stool among adult TB presumptive patients in Uganda.
    Sessolo A; Musisi E; Kaswabuli S; Zawedde J; Byanyima P; Sabiiti W; Walimbwa S; Ola J; Sanyu I; Lalitha R; Kamya M; Davis L; Worodria W; Huang L
    PLoS One; 2023; 18(4):e0284041. PubMed ID: 37083706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xpert MTB/RIF assay in the diagnosis of pulmonary tuberculosis in children in tertiary care setting in South India.
    Velayutham B; Hissar S; Thiruvengadam K; Narayan Sivaramakrishnan G; Subramanyam B; Navaneethapandian P; Reddy D; Nair D; Kannabiran B; Balaji S; Selladurai E; Ganesh J; Aravind MA; Rathinam P; Chellaiah LR; Rose W; Luke Elizabeth H; Sakaya A; Joseph B; Sundaralingam V; Karthikeyan S; Dhanaraj B; Natrajan M; Swaminathan S
    J Trop Pediatr; 2024 Aug; 70(5):. PubMed ID: 39152039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out.
    Muttamba W; Ssengooba W; Sekibira R; Kirenga B; Katamba A; Joloba M
    PLoS One; 2018; 13(3):e0194741. PubMed ID: 29566056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Mycobacterium tuberculosis Bacillary Loads Detected by Tuberculosis Molecular Bacterial Load Assay in Patient Stool: a Potential Alternative for Nonsputum Diagnosis and Treatment Response Monitoring of Tuberculosis.
    Musisi E; Sessolo A; Kaswabuli S; Zawedde J; Byanyima P; Kasinga S; Sanyu I; Uwimaana E; Walimbwa S; Olore J; Ssengooba W; Sekaggya C; Joloba ML; Worodria W; Huang L; Gillespie SH; Sloan DJ; Sabiiti W
    Microbiol Spectr; 2022 Feb; 10(1):e0210021. PubMed ID: 35019686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of OMNIgene·SPUTUM performance in delayed tuberculosis testing by smear, culture, and Xpert MTB/RIF assays in Uganda.
    Kelly-Cirino CD; Musisi E; Byanyima P; Kaswabuli S; Andama A; Sessolo A; Sanyu I; Zawedde J; Curry PS; Huang L
    J Epidemiol Glob Health; 2017 Jun; 7(2):103-109. PubMed ID: 28413105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light-emitting diode fluorescent microscopy and Xpert MTB/RIF® assay for diagnosis of pulmonary tuberculosis among patients attending Ambo hospital, west-central Ethiopia.
    Gelalcha AG; Kebede A; Mamo H
    BMC Infect Dis; 2017 Sep; 17(1):613. PubMed ID: 28893193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis.
    Singh S; Singh A; Prajapati S; Kabra SK; Lodha R; Mukherjee A; Singh V; Hesseling AC; Grewal HM;
    BMC Microbiol; 2015 Sep; 15():191. PubMed ID: 26420261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study.
    Namugenyi J; Musaazi J; Katamba A; Kalyango J; Sendaula E; Kambugu A; Fehr J; Castelnouvo B; Manabe YC; Ssengooba W; Sekaggya-Wiltshire C
    BMC Infect Dis; 2021 Jun; 21(1):513. PubMed ID: 34074248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of Xpert MTB/RIF assay and non-molecular methods for the diagnosis of tuberculosis lymphadenitis.
    Fantahun M; Kebede A; Yenew B; Gemechu T; Mamuye Y; Tadesse M; Brhane B; Jibriel A; Solomon D; Yaregal Z
    PLoS One; 2019; 14(9):e0222402. PubMed ID: 31525214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.
    Bates M; Ahmed Y; Chilukutu L; Tembo J; Cheelo B; Sinyangwe S; Kapata N; Maeurer M; O'Grady J; Mwaba P; Zumla A
    Trop Med Int Health; 2013 Sep; 18(9):1134-1140. PubMed ID: 23834035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental yield of serial sputum cultures for diagnosis of tuberculosis among HIV infected smear negative pulmonary TB suspects in Kampala, Uganda.
    Ssengooba W; Kiwanuka N; Kateete DP; Katamba A; Joloba ML
    PLoS One; 2012; 7(5):e37650. PubMed ID: 22629439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
    Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
    BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microscopic observation drug-susceptibility assay vs. Xpert
    Wikman-Jorgensen PE; Llenas-García J; Pérez-Porcuna TM; Hobbins M; Ehmer J; Mussa MA; Ascaso C
    Trop Med Int Health; 2017 Jun; 22(6):734-743. PubMed ID: 28380276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial.
    Bunyasi EW; Tameris M; Geldenhuys H; Schmidt BM; Luabeya AK; Mulenga H; Scriba TJ; Hanekom WA; Mahomed H; McShane H; Hatherill M
    PLoS One; 2015; 10(11):e0141623. PubMed ID: 26554383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective cross-sectional evaluation of the small membrane filtration method for diagnosis of pulmonary tuberculosis.
    Jones-López E; Manabe YC; Palaci M; Kayiza C; Armstrong D; Nakiyingi L; Ssengooba W; Gaeddert M; Kubiak R; Almeida Júnior P; Alland D; Dietze R; Joloba M; Ellner JJ; Dorman SE
    J Clin Microbiol; 2014 Jul; 52(7):2513-20. PubMed ID: 24808236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda.
    Meyer AJ; Atuheire C; Worodria W; Kizito S; Katamba A; Sanyu I; Andama A; Ayakaka I; Cattamanchi A; Bwanga F; Huang L; Davis JL
    PLoS One; 2017; 12(7):e0180572. PubMed ID: 28686705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
    Orikiriza P; Nansumba M; Nyehangane D; Bastard M; Mugisha IT; Nansera D; Mwanga-Amumpaire J; Boum Y; Kumbakumba E; Bonnet M
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1465-1473. PubMed ID: 29740714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.